The VESALIUS-CV Trial
|
May 6, 2026 | Paul Burton and C. Michael Gibson discuss the effects of adding evolocumab for patients at high risk for CV events but without prior MI or stroke. |
New at TCTMD? Register today!
Enter the email you used to register to reset your password.